This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


MiraLAX® Laxative Now Available Over The Counter


KENILWORTH, N.J. -- Schering-Plough Corporation announced that prescription-strength MiraLAX® (polyethylene glycol 3350) is now available as an over-the-counter (OTC) treatment for occasional constipation. This formula of MiraLAX works with the body to increase the frequency of bowel movements without causing the side effects of cramps and gas. MiraLAX allows a comfortable, easy and complete bowel movement. MiraLAX has a strong safety profile and is not known to be habit forming.

"Laxatives that work gently with the body are preferred because people can live their lives normally. Some other laxatives may cause uncomfortable cramps. MiraLAX offers effective constipation relief, allowing the patient to regain control," said Jack A. DiPalma, MD, immediate past president of the American College of Gastroenterology and director of the division of gastroenterology at University of South Alabama College of Medicine.

MiraLAX is the first Rx-to-OTC switch in the laxative category in 30 years. MiraLAX uses the body's own water to gently increase the frequency of bowel movements and to soften the stool so it is easier to pass. MiraLAX is taken once daily and comes in a powder form that dissolves completely in any common beverage (coffee, tea, juice, soda).

Constipation is a common gastrointestinal complaint, affecting more than 65 million Americans.1 Constipation can stem from lifestyle causes such as diet and inadequate fluid intake; physical inactivity; stress or anxiety; and medical conditions such as pregnancy, diabetes or hypothyroidism.2 Constipation can also be caused or exacerbated by narcotic analgesics, antacids, anticholinergics or iron supplements. On average, more than twice as many women as men suffer from constipation.1

1. Higgins, Peter D.R., & Johanson, John F. Epidemiology of constipation in North America: a systematic review. American Journal of Gastroenterology. 2004; 99, 750-759.
2. DeLillo A.R. & Rose, S. Functional bowel disorders in the geriatric patient: constipation, fecal impaction and fecal incontinence. American Journal of Gastroenterology. 2000; 95, 901-905.

Source: Schering-Plough Corporation

comments powered by Disqus